Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2005 1
2006 1
2007 2
2008 4
2009 5
2010 4
2011 2
2012 4
2013 4
2014 3
2015 2
2016 1
2017 2
2018 4
2019 7
2020 5
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

45 results
Results by year
Filters applied: . Clear all
Page 1
A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis.
Rovin BH, Solomons N, Pendergraft WF 3rd, Dooley MA, Tumlin J, Romero-Diaz J, Lysenko L, Navarra SV, Huizinga RB; AURA-LV Study Group. Rovin BH, et al. Among authors: navarra sv. Kidney Int. 2019 Jan;95(1):219-231. doi: 10.1016/j.kint.2018.08.025. Epub 2018 Nov 9. Kidney Int. 2019. PMID: 30420324 Clinical Trial.
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.
Navarra SV, Guzmán RM, Gallacher AE, Hall S, Levy RA, Jimenez RE, Li EK, Thomas M, Kim HY, León MG, Tanasescu C, Nasonov E, Lan JL, Pineda L, Zhong ZJ, Freimuth W, Petri MA; BLISS-52 Study Group. Navarra SV, et al. Lancet. 2011 Feb 26;377(9767):721-31. doi: 10.1016/S0140-6736(10)61354-2. Epub 2011 Feb 4. Lancet. 2011. PMID: 21296403 Clinical Trial.
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS).
Franklyn K, Lau CS, Navarra SV, Louthrenoo W, Lateef A, Hamijoyo L, Wahono CS, Chen SL, Jin O, Morton S, Hoi A, Huq M, Nikpour M, Morand EF; Asia-Pacific Lupus Collaboration. Franklyn K, et al. Among authors: navarra sv. Ann Rheum Dis. 2016 Sep;75(9):1615-21. doi: 10.1136/annrheumdis-2015-207726. Epub 2015 Oct 12. Ann Rheum Dis. 2016. PMID: 26458737
Long-term safety and limited organ damage in patients with systemic lupus erythematosus treated with belimumab: a Phase III study extension.
van Vollenhoven RF, Navarra SV, Levy RA, Thomas M, Heath A, Lustine T, Adamkovic A, Fettiplace J, Wang ML, Ji B, Roth D. van Vollenhoven RF, et al. Among authors: navarra sv. Rheumatology (Oxford). 2020 Feb 1;59(2):281-291. doi: 10.1093/rheumatology/kez279. Rheumatology (Oxford). 2020. PMID: 31302695 Free PMC article. Clinical Trial.
Biologic therapies in systemic lupus erythematosus.
Bernal CB, Zamora LD, Navarra SV. Bernal CB, et al. Among authors: navarra sv. Int J Rheum Dis. 2015 Feb;18(2):146-53. doi: 10.1111/1756-185X.12490. Int J Rheum Dis. 2015. PMID: 25884458 Review.
Infections in systemic lupus erythematosus.
Navarra SV, Leynes MS. Navarra SV, et al. Lupus. 2010 Oct;19(12):1419-24. doi: 10.1177/0961203310374486. Lupus. 2010. PMID: 20947551 Review.
Lupus registries: evolution and challenges.
Lu LJ, Wallace DJ, Navarra SV, Weisman MH. Lu LJ, et al. Among authors: navarra sv. Semin Arthritis Rheum. 2010 Feb;39(4):224-45. doi: 10.1016/j.semarthrit.2008.08.009. Epub 2008 Nov 7. Semin Arthritis Rheum. 2010. PMID: 18992923 Review.
Lupus in the developing world--is it any different?
Tikly M, Navarra SV. Tikly M, et al. Among authors: navarra sv. Best Pract Res Clin Rheumatol. 2008 Aug;22(4):643-55. doi: 10.1016/j.berh.2008.05.003. Best Pract Res Clin Rheumatol. 2008. PMID: 18783742 Review.
Practice Advisory on the Appropriate Use of NSAIDs in Primary Care.
Ho KY, Cardosa MS, Chaiamnuay S, Hidayat R, Ho HQT, Kamil O, Mokhtar SA, Nakata K, Navarra SV, Nguyen VH, Pinzon R, Tsuruoka S, Yim HB, Choy E. Ho KY, et al. Among authors: navarra sv. J Pain Res. 2020 Aug 3;13:1925-1939. doi: 10.2147/JPR.S247781. eCollection 2020. J Pain Res. 2020. PMID: 32821151 Free PMC article. Review.
45 results